Depending on the value of the shape parameter , the upper limit of the 95% confidence interval (CI) for 1 demonstrates an increasing hazard over time (wear-out failure type), whereas the 95% CI includes 1 for , suggesting a constant hazard rate throughout the exposure period (random failure type)
However, only 41.8% stayed on treatment at 6 months 109 , in line with the available literature reporting disappointingly low adherence to liraglutide for obesity management and raising concerns about its role in the lifelong challenge of BW control and weight-related complications 110
(2022) "Tirzepatide Once Weekly for the Treatment of Obesity" The New England Journal of Medicine, 387(3) This article was reviewed and approved by Alice Fletcher, Lead Bariatric Dietitian, on 29 September 2025
This led the FDA to remove its dietary supplement status [33]
Theres no such thing as GLP-3. GLP-2 exists, but retatrutide has nothing to do with it